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Abstract 
The link among ADHD and addiction is increasingly shifting into the focus of 
scientific study.  It becomes obvious that ADHD functions as a risk factor 
and condition for dependence.  Disturbances in psychosocial functioning and 
the tendency towards substance abuse are highly correlated. Objective: This 
overview relies on a Medline research. Its objective is to describe the joint 
characteristics among ADHD and addiction. We especially focus on the 
neurobiological similarities between both diseases.  Results: The results of 
this literature review support the hypothesis of a close genetic, neurological 
and phenotypic linkage between ADHD and addiction. Furthermore, ADHD 
often serves as the source for substance abuse disorders among youths and 
adults. Conclusions: The increasing clinical meaning of the overlap among 
ADHD and addiction urgently necessitates for consideration regarding 
preventive planning.  
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Attention deficit hyperactivity disorder 
(ADHD) is a common, childhood-onset 
neurodevelopmental disorder with adverse 
consequences during adult life. It affects up 
to 10 % of children (1) and is associated 
with a wide range of impairments (2). The 
disorder is characterized by developmentally 
inappropriate levels of inattention, 
impulsivity or hyperactivity. ADHD may 
have a serious and harmful impact on a 
child’s or adolescents psychosocial 
functioning. Adolescents with ADHD are far 
more likely to exhibit academic 
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underachievement, poor rapport and 
diminished self-esteem. 
Substance disorder is a chronic, relapsing 
disorder in which compulsive drug-seeking 
and drug-taking behaviors persist despite 
serious negative consequences (3). The 
onset of substance use disorders usually 
begins in adolescence or early adulthood, 
mostly before the age of 20. The levels of 
drug use among youths under 14 are 
extremely low. Prevalence of cannabis use 
for example is 5.8% in the general United 
States population (4). 
Already in 1986 coherence among addiction 
and ADHD has been suspected (5). Almost 
8 years later the assumption has been 
approved in clinical research (6, 7). The 
strong interrelationship among ADHD and 
addiction was also shown by   Biedermann 
in 1995 (8). This survey proved the high 
comorbidities among ADHD and addiction. 
The comparison of existing comorbidities 
within a clinical group of 120 patients with 
ADHD revealed 52% as drug addicted in 
comparison with 27% of the control group. 
Research on drug addiction shows a co-
morbid prevalence of 50% in hyperkinetic 
disorder, whereas the prevalence in average 
population is about 5 % (9, 10). Recent 
studies likewise indicate an 
overrepresentation of ADHD in addicted 
adults. For example, studies of alcohol 
abusers yielded rates of 35% to 71% of adult 
alcoholics with childhood-onset and 
persistent ADHD (11). Including both, 
alcohol and drug addiction, 15% to 25% of 
adult addicts and alcoholics have current 
ADHD. For example, Schubiner et al. (12) 
found that 24% of 201 inpatients in a 
substance abuse treatment facility had 
ADHD, and that two thirds of them also had 
conduct disorder. The presence of ADHD 
also impacts the characteristics of cigarette 
smoking and substance use disorder (SUD). 
Adults with ADHD and SUD histories have 
been reported to have earlier onset of 
cigarette smoking and substance abuse 
compared with adults without ADHD (13). 
Additionally, more severe SUD has been 
reported in ADHD adults compared with 
adults without ADHD (14). 
This overlap between ADHD and substance 
disorder has been an area of increasing 
clinical, research and public health interest. 
An important question is whether this is 
accidental, simply overlapping or the 
consequence of one another. New findings 
of genetic research are to be considered.  
Family, twin and adoption studies show that 
genetic factors contribute to the etiology of 
ADHD and that environmental factors also 
play a role. These studies have shown the 
importance of genetic influences on 
continuity in ADHD over time and in 
accounting for the co-occurrence of ADHD 
and conduct disorder problems (15). In 
meta-analyses of molecular genetic studies 
the dopamine D4 gene and the D5 receptor 
gene have been found to be repeatedly 
associated with ADHD. This is proved 
already in earlier investigations: Many 
candidate gene studies of ADHD have 
produced substantial evidence implicating 
several genes in the etiology of the disorder. 
For the 8 genes for which the same variant 
has been studied in 3 or more case-control or 
family-based studies, 7 show statistically 
significant evidence of association with 
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ADHD based on pooled odds ratios across 
studies: The dopamine D4 receptor gene 
(DRD4), the dopamine D5 receptor gene 
(DRD5), and the dopamine transporter gene 
(DAT) (16). Recent research confirms these 
findings: significant heterogeneity was 
observed for the associations among ADHD 
and – for example - DAT1, DRD4, and 
DRD5 (17). 
Twin, family, and adoption studies show 
that genetic factors play a significant role in 
vulnerability to becoming addicted to drugs 
(18). Drug addiction is a brain disease with 
complex genetic, psychological and social 
factors. The dopaminergic system of the 
brain plays a central role in natural reward 
and motivation and is the main neural 
substrate for the actions of abusive drugs. 
The dopaminergic and opioidergic reward 
pathways of the brain are crucial for survival 
since they provide the pleasure drives for 
eating, love and reproduction; these are 
called 'natural rewards' and involve the 
release of dopamine in the nucleus 
accumbens and frontal lobes. However, the 
same release of dopamine and production of 
sensations of pleasure can be produced by 
'unnatural rewards' such as alcohol, cocaine, 
methamphetamine, heroin, nicotine, 
marijuana and other drugs, and by 
compulsive activities such as gambling, 
eating,  sex, and  risk taking behaviors. The 
analysis of mice with mutations in their 
dopamine receptor genes has provided new 
information regarding the influence of 
individual dopamine receptors on drug 
actions. (19). Dopamine transmission within 
cortical and subcortical structures is 
involved critically in the processing of 
emotionally relevant sensory information. 
Three interconnected neural regions, the 
medial prefrontal cortex, basolateral nucleus 
of the amygdala and the ventral tegmental 
area have received considerable 
experimental attention, both in animal and 
clinical research models, as essential 
interconnected processors of emotional 
information. Neuronal network disturbances 
in D (4)-receptor related neural circuitry 
may be involved in the neuropathological 
manifestations common in many 
neuropsychiatric disorders including 
schizophrenia, attention-deficit hyperactivity 
disorder and addiction (20). Studies have 
shown that in various subject groups parts of 
the DRD2 gene are associated with 
alcoholism, drug abuse, smoking, obesity, 
compulsive gambling, and several 
personality traits. (21). A recent review (22) 
indicates that different aspects of the 
addiction phenotype are critically influenced 
by dopaminergic receptors and that variants 
of those genes seem to influence some 
addiction phenotypes in humans. 
This short overlook stresses the evidence of 
serious connections among ADHD and 
substance disorder. Further investigations of 
prevalence, genetic relations, and affinities 
will urgently be necessary to highlight 
enhanced prevention. 
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